Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Genflow Biosciences - London-based biotechnology company focused on longevity, with research & development facilities in Belgium - Names Tamara Joseph, a US-based non-executive director, as new chair. Points out Joseph has an impressive track record in public and private financings, having supported Nasdaq financings in excess of $800 million.
In April, Genflow submitted an application for trading of its shares on the OTCQB Venture Market in the US. Genflow says Yassine Bendiabdallah, will remain a non-executive Director. Further, appoints Vera Gorbunova as Chair of the Scientific Advisory Board and says Dr Sven Francque is joining the SAB.
Current stock price: 3.05 pence, down 2.4% in London on Thursday
12-month change: down 61%
Copyright 2023 Alliance News Ltd. All Rights Reserved.